메뉴 건너뛰기




Volumn 25, Issue 7, 2011, Pages 1219-1220

DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; DNA; DNA METHYLTRANSFERASE 3A; JANUS KINASE 2; K RAS PROTEIN;

EID: 79960248721     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.82     Document Type: Article
Times cited : (120)

References (5)
  • 3
    • 79960255863 scopus 로고    scopus 로고
    • Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
    • e-pub ahead of print 18 March 2011
    • Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011; e-pub ahead of print 18 March 2011.
    • (2011) Leukemia
    • Walter, M.J.1    Ding, L.2    Shen, D.3    Shao, J.4    Grillot, M.5    McLellan, M.6
  • 4
    • 79960227474 scopus 로고    scopus 로고
    • Concomitant analysis of ASXL1 and EZH2 mutations in myelofibrosis, chronic myelomonocytic leukemia, and blast-phase myeloproliferative neoplasms
    • e-pub ahead of print 01 April 2011
    • Abdel-Wahab O, Pardanani A, Patel J, Wadleigh M, Lasho T, Heguy A et al. Concomitant analysis of ASXL1 and EZH2 mutations in myelofibrosis, chronic myelomonocytic leukemia, and blast-phase myeloproliferative neoplasms. Leukemia 2011; e-pub ahead of print 01 April 2011.
    • (2011) Leukemia
    • Abdel-Wahab, O.1    Pardanani, A.2    Patel, J.3    Wadleigh, M.4    Lasho, T.5    Heguy, A.6
  • 5
    • 77950352432 scopus 로고    scopus 로고
    • A dynamic prognostic model to predict survival in primary myelofibrosis: A study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
    • Passamonti F, Cervantes F, Vannucchi AM, Morra E, Rumi E, Pereira A et al. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment). Blood 2010; 115: 1703-1708.
    • (2010) Blood , vol.115 , pp. 1703-1708
    • Passamonti, F.1    Cervantes, F.2    Vannucchi, A.M.3    Morra, E.4    Rumi, E.5    Pereira, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.